SHSimon J. Hambidge

Simon J. Hambidge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simon J. Hambidge has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Influenza vaccination accuracy among adults: Self-report compared with electronic health record data

    by Matthew F. Daley, Liza M. Reifler, Jo Ann Shoup, Jason M. Glanz, Bruno J. Lewin, Nicola P. Klein, Elyse O. Kharbanda, Huong Q. McLean, Simon J. Hambidge, Jennifer C. Nelson, et al.


  • Open Access

    Costs to Implement a Pediatric Weight Management Program Across 3 Distinct Contexts

    by Natalie Riva Smith, Meg Simione, Haley Ma Farrar-Muir, Jazmin Bs Granadeno, Jennifer W. Moreland, Jessica Mshs Wallace, Holly M. Frost, Jackie Bs Young, Cassie Craddock, Kerry Sease, et al.

    Background: The Connect for Health program is an evidence-based program that aligns with national recommendations for pediatric weight management and includes clinical decision support, educational handouts, and community resources. As implementation costs are a major driver of program adoption and maintenance decisions, we assessed the costs to implement the Connect for Health program across 3 health systems that primarily serve low-income communities with a high prevalence of childhood obesity. Methods: We used time-driven activity-based costing methods. Each health system (site) developed a process map and a detailed report of all implementation actions taken, aligned with major implementation requirements (eg, electronic health record integration) or strategies (eg, providing clinician training). For each action, sites identified the personnel involved and estimated the time they spent, allowing us to estimate the total costs of implementation and breakdown costs by major implementation activities. Results: Process maps indicated that the program integrated easily into well-child visits. Overall implementation costs ranged from $77,103 (Prisma Health) to $84,954 (Denver Health) to $142,721 (Massachusetts General Hospital). Across implementation activities, setting up the technological aspects of the program was a major driver of costs. Other cost drivers included training, engaging stakeholders, and audit and feedback activities, though there was variability across systems based on organizational context and implementation choices. Conclusions: Our work highlights the major cost drivers of implementing the Connect for Health program. Accounting for context-specific considerations when assessing the costs of implementation is crucial, especially to facilitate accurate projections of implementation costs in future settings.


  • Integration of data from a safety net health care system into the Vaccine Safety Datalink

    by Simon J. Hambidge, Colleen Ross, Jo Ann Shoup, Kris Wain, Komal Narwaney, Kristin Breslin, Eric S. Weintraub, Michael M. McNeil


  • Association of TDAP Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations

    by Lakshmi Sukumaran, Natalie L. McCarthy, Elyse O. Kharbanda, Michael M. McNeil, Allison L. Naleway, Nicola P. Klein, Michael L. Jackson, Simon J. Hambidge, Marlene M. Lugg, Rongxia Li, et al.

  • Open Access

    A randomized, home-based, childhood obesity intervention delivered by patient navigators

    by Lourdes Yun, Richard E. Boles, Matthew A. Haemer, Shanna Knierim, L. Miriam Dickinson, Heather Mancinas, Simon J. Hambidge, Arthur J. Davidson

    Although Colorado is perceived as a healthy state, in 2010, 14.1 % of children aged 2–5 were overweight and 9.1 % were obese. Despite the high prevalence of obesity in this population, evidence to support particular strategies to treat obese preschoolers is lacking. The efficacy of home-based, childhood obesity interventions to reduce a child’s body mass index is inconclusive. However, this model uniquely provides an opportunity to observe and intervene with the home food and activity environment and engage the entire family in promoting changes that fit each family’s unique dynamics. Eligible participants are children aged 2–5 years who attended a well-child care visit at a Denver Health Community Health Service clinic within 12 months prior to recruitment and on that visit had a body mass index (BMI) >85th percentile-for-age. Participants are randomly recruited at study inception and allocated to the intervention in one of five defined 6-month stepped wedge engagements; the delayed intervention groups serves as control groups until the start of the intervention. The program is delivered by a patient navigator at the family’ home and consists of a 16-session curriculum focused on 1) parenting styles, 2) nutrition, and 3) physical activity. At each visit, a portion of curriculum is delivered to guide parents and children in selecting one goal for behavior change in each of three work areas to work on during the following week. The primary study outcome measure is change in BMI z-score from baseline to post-intervention period. This childhood obesity study, innovative for its home-based intervention venue, provides rich data characterizing barriers and facilitators to healthy behavior change within the home. The study population is innovative as it is focused on preschool-aged, Latino children from low-income families; this population has not typically been targeted in obesity management assessments. The home-based intervention is linked to clinical care through update letters and assessment of the program’s impact to the child’s medical providers. Informing primary care providers about a child’s accomplishments and challenges, allows the clinician to support the health weight effort when seeing families during subsequent clinical visits. ClinicalTrials.gov NCT02024360 Registered December 21, 2013


  • What Can Providers Learn From Childhood Body Mass Index Trajectories: A Study of a Large, Safety-Net Clinical Population

    by Emily V. McCormick, L. Miriam Dickinson, Matthew A. Haemer, Shanna D. Knierim, Simon J. Hambidge, Arthur J. Davidson


  • Open Access

    Timely Versus Delayed Early Childhood Vaccination and Seizures

    by Simon J. Hambidge, Sophia R. Newcomer, Komal J. Narwaney, Jason M. Glanz, Matthew F. Daley, Stan Xu, Jo Ann Shoup, Ali Rowhani-Rahbar, Nicola P. Klein, Grace M. Lee, et al.

    BACKGROUND: Little is known regarding the timing of childhood vaccination and postvaccination seizures. METHODS: In a cohort of 323 247 US children from the Vaccine Safety Datalink born from 2004 to 2008, we analyzed the association between the timing of childhood vaccination and the first occurrence of seizure with a self-controlled case series analysis of the first doses of individual vaccines received in the first 2 years of life. RESULTS: In infants, there was no association between the timing of infant vaccination and postvaccination seizures. In the second year of life, the incident rate ratio (IRR) for seizures after receipt of the first measles-mumps-rubella vaccine (MMR) dose at 12 to 15 months was 2.65 (95% confidence interval [CI] 1.99–3.55); the IRR after an MMR dose at 16 to 23 months was 6.53 (95% CI 3.15–13.53). The IRR for seizures after receipt of the first measles-mumps-rubella-varicella vaccine (MMRV) dose at 12 to 15 months was 4.95 (95% CI 3.68–6.66); the IRR after an MMRV dose at 16 to 23 months was 9.80 (95% CI 4.35 –22.06). CONCLUSIONS: There is no increased risk of postvaccination seizure in infants regardless of timing of vaccination. In year 2, delaying MMR vaccine past 15 months of age results in a higher risk of seizures. The strength of the association is doubled with MMRV vaccine. These findings suggest that on-time vaccination is as safe with regard to seizures as delayed vaccination in the first year of life, and that delayed vaccination in the second year of life is associated with more postvaccination seizures than on-time vaccination.


  • Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine

    by Matthew F. Daley, W. Katherine Yih, Jason M. Glanz, Simon J. Hambidge, Komal J. Narwaney, Ruihua Yin, Lingling Li, Jennifer C. Nelson, James D. Nordin, Nicola P. Klein, et al.


  • Open Access

    Bias Correction of Risk Estimates in Vaccine Safety Studies With Rare Adverse Events Using a Self-controlled Case Series Design

    by Chan Zeng, Sophia R. Newcomer, Jason M. Glanz, Jo Ann Shoup, Matthew F. Daley, Simon J. Hambidge, Stanley Xu

    The self-controlled case series (SCCS) method is often used to examine the temporal association between vaccination and adverse events using only data from patients who experienced such events. Conditional Poisson regression models are used to estimate incidence rate ratios, and these models perform well with large or medium-sized case samples. However, in some vaccine safety studies, the adverse events studied are rare and the maximum likelihood estimates may be biased. Several bias correction methods have been examined in case-control studies using conditional logistic regression, but none of these methods have been evaluated in studies using the SCCS design. In this study, we used simulations to evaluate 2 bias correction approaches—the Firth penalized maximum likelihood method and Cordeiro and McCullagh's bias reduction after maximum likelihood estimation—with small sample sizes in studies using the SCCS design. The simulations showed that the bias under the SCCS design with a small number of cases can be large and is also sensitive to a short risk period. The Firth correction method provides finite and less biased estimates than the maximum likelihood method and Cordeiro and McCullagh's method. However, limitations still exist when the risk period in the SCCS design is short relative to the entire observation period.